Insights & Resources

Wyoming House Bill 11 expands the manufacturing sales and use tax exemptions. We break down what this means for businesses operating in Wyoming.

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

Learn how HMRC's guidelines impact transfer pricing for life sciences and other multinationals and how to mitigate risks and ensure compliance.

Explore the top five impacts tariffs may have on your business taxes and learn steps and key strategies to manage costs, credits and compliance.

The National Association of Manufacturers (NAM) has released its Q4 Manufacturers’ Survey. Learn more about what it means for leadership in 2025.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

With 2024 coming to a close, time is running out for manufacturing companies to take advantage of many year-end tax benefits.

CEOs can leverage established ESG principles and best practices to create sustainable business operations and promote long-term growth.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

Discover key insights from NAM's Q2 2024 survey on manufacturing industry challenges, workforce issues and the impact of potential tax increases.